Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 10:16 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 25 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: West Cancer Center Clear all

Conditions: Cachexia, Neoplasms
Interventions: standard care, nutritional supplements and advice, home-based self-assisted exercise program, Ibuprofen; Other · Dietary Supplement · Behavioral + 1 more
Lead sponsor: Norwegian University of Science and Technology; Other
Eligibility: 18 Years and older
Enrollment: 221 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Breast Cancer, Fatigue
Interventions: Walk With Ease Arm A; Behavioral
Lead sponsor: The West Clinic, Memphis; Industry
Eligibility: 65 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Memphis, Tennessee

Conditions: Other Cancer, Gastrointestinal Cancer, Thoracic Cancer, Gynecologic Cancer
Interventions: Stakeholder Survey (Control Period), Stakeholder Survey (Intervention Period), Qualitative Interview, SASS Questionnaire, eSyM; Other
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 42,808 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 6
States / cities: Portland, Maine • Boston, Massachusetts • Lebanon, New Hampshire + 3 more

Conditions: Colorectal, Cancer, Screening, Intervention
Interventions: Generic Print Intervention, Tailored Print Intervention, Tailored print plus tailored phone intervention; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 40 Years and older
Enrollment: 213 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Neoplasm Female
Interventions: THRIVE App, Tailored Feedback Messages; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 110 Years · Female only
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 2
States / cities: Memphis, Tennessee

Conditions: Bladder Cancer
Interventions: paclitaxel; Drug
Lead sponsor: Mary Babb Randolph Cancer Center at West Virginia University Hospitals; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2004
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Prostate Cancer
Interventions: Flutamide (Eulexin) and Lupron or Zoladex, External Beam Radiotherapy; Drug · Radiation
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 41 Years and older · Male only
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1995 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: High Grade Gliomas, Glioblastoma, Astrocytoma, Oligodendroglioma
Interventions: Pre-radiation temozolomide.; Drug
Lead sponsor: Cooper Norcross Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: C.Surgical Procedure; Disruption of Wound, Suture
Interventions: Stratafix suture, Standard of care suture; Device
Lead sponsor: West Michigan Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Kalamazoo, Michigan

Conditions: COVID-19
Interventions: Remdesivir, Imatinib Mesylate, Dexamethasone, Cenicriviroc, Icatibant, Apremilast, dornase alfa, Celecoxib, Famotidine, IC14, Aviptadil, narsoplimab, Cyproheptadine, Cyclosporine; Drug · Biological
Lead sponsor: QuantumLeap Healthcare Collaborative; Other
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 36
States / cities: Birmingham, Alabama • Davis, California • Irvine, California + 30 more

Conditions: Chemotherapy Effect
Interventions: Comparator App; Behavioral
Lead sponsor: West Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 3
States / cities: Southaven, Mississippi • Germantown, Tennessee • Memphis, Tennessee

Conditions: Non-Small Cell Lung Cancer
Interventions: Not listed
Lead sponsor: Scientific Institute San Raffaele; Other
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 3
States / cities: Miami, Florida • New York, New York • Morgantown, West Virginia

Conditions: Homologous Recombination Deficient Solid Tumors
Interventions: Combination drug; Drug
Lead sponsor: West Cancer Center; Other
Eligibility: Up to 100 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Germantown, Tennessee

Conditions: Melanoma, BRAF Gene Mutation
Interventions: Talimogene Laherparepvec 1 Million Pfu/Ml Inj,Susp,1Ml,Vil, Talimogene Laherparep 100 Mil Pfu/Ml 1Ml, Dabrafenib, Trametinib; Drug
Lead sponsor: West Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Germantown, Tennessee

Conditions: Hypertension
Interventions: Cellular enabled blood pressure cuff, Standard of Care Cuff; Device
Lead sponsor: West Michigan Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Kalamazoo, Michigan

Conditions: Cancer
Interventions: Nurse AMIE, Usual Care; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 344 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 8
States / cities: Butler, Pennsylvania • Greenville, Pennsylvania • Hershey, Pennsylvania + 5 more

Conditions: Prostate Cancer
Interventions: brachytherapy; Radiation
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older · Male only
Enrollment: 414 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2011
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Triple Negative Breast Cancer, Early-stage Breast Cancer, HER2-positive Breast Cancer
Interventions: Neratinib; Drug
Lead sponsor: West Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Germantown, Tennessee

Conditions: Educational Activities
Interventions: PEDSS - symptom management, PEDSS - support for the caregiver; Other
Lead sponsor: Duke University; Other
Eligibility: 3 Years to 17 Years
Enrollment: 289 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 15
States / cities: Miami, Florida • Chicago, Illinois • Winfield, Illinois + 12 more

Conditions: Breast Cancer, Prostate Cancer
Interventions: Standard of Care; Other
Lead sponsor: Fox Chase Cancer Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 854 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Head and Neck Cancer
Interventions: IMRT, cetuximab, docetaxel; Radiation
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 6
States / cities: Omaha, Nebraska • Basking Ridge, New Jersey • Commack, New York + 3 more

Conditions: Genital Neoplasm, Female
Interventions: Discharge instructions reminders, Prompts to report symptoms via the web-enabled app, Clinical Alerts; Behavioral
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years and older · Female only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 3
States / cities: Southaven, Mississippi • Memphis, Tennessee

Conditions: Breast Neoplasm Female
Interventions: Prompts to report symptoms via study app, Clinical Alerts; Behavioral
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years and older · Female only
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Memphis, Tennessee

Conditions: Skin Lesion, Skin Cancer, Skin Melanoma, Tumor Skin
Interventions: Oxygen; Other
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Morgantown, West Virginia

Search by objective public record fields.

Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy

The Effect of Walking on Fatigue During Radiotherapy in Breast Cancer Patients 65 and Older

Symptom Management Implementation of Patient Reported Outcomes in Oncology

Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients

THRIVE Breast Cancer App Study

Paclitaxel in Treating Patients With Early-Stage Bladder Cancer

Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer

Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.

Use of Stratafix Symmetric™ to Prevent Incisional Hernia in Gastrointestinal and Abdominal Surgery

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Evaluation of a Mobile App to Promote Social Support for Oncology Patients

Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers

Niraparib and Dostarlimab in HRD Solid Tumors

Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma

Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer

Nurse AMIE (Addressing Malignancies in Individuals Everyday)

Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer

Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast

Parent Educational Discharge Support Strategies

African Cancer Genome: GMD

Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer

Post-Operative Gynecological Oncology App Study

Web-Base App To Improve Aromatase Inhibitor Adherence

Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry